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Abstract: Cancer is a complex disease because it makes complex cellular changes. Therefore, 
microarrays have become a powerful way to analyse cancer and identify what changes are produced within a 
cell. Through DNA microarrays, it has become possible to look at the expression of thousands of genes in 
one sample and this is called gene expression profiling. Gene expression profiling is important to capture a 
set of expressed genes that determines a cell phenotype. 
However, analysing microarray data is challenged by the high-dimensionality of the data compared with the 
number of samples. The aim of this study was to enhance the diagnostic accuracy of Breast Cancer Computer 
Aided Diagnostic Systems (CADs) that use gene expression profiling of peripheral blood cells, by 
introducing a novel feature selection method called Bi-biological filter that was further refined by Best First 
Search with Support Vector Machines SVM (BFS-SVM) to select a small set of the most effective genes 
predictive of breast cancer. From each patient’s gene expression profiles, a gene co-expression network was 
built and divided into functional groups or clusters using Topological Overlap Matrix (TOM) and Spectral 
Clustering (SC) in the design of the Bi-Biological filter to obtain the preliminary set of gene markers. BFS-
SVM was used to further filter a smaller set of best gene markers, and Artificial Neural Networks (ANN), 
SVM and Linear Discriminant Analysis (LDA) were used to assess their classification performance. The 
study used 121 samples – 67 malignant and 54 benign cases as input to for the system. The Bi-biological 
filter selected 415 genes as mRNA biomarkers and BFS-SVM was able to select just 13 out of 415 genes for 
classification of breast cancer. ANN was found to be the superior classifier with 93.4% classification 
accuracy which was a 14% improvement over the past best CAD system developed by Aaroe et al. (2010).  
Keywords: gene expression, mRNA, blood, feature selection, neural networks, breast cancer, 
Computer Aided Diagnosis, early detection 
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1. INTRODUCTION 
Gene expression profiling of peripheral blood cells has been used for early detection of breast cancer. 
However, analysing microarray data is challenged by the high-dimensionality of the data compared with the 
number of samples. Most of the previous studies in this field have used either filters or wrappers to select a 
subset of genes that differentiate cancer from control cases (Aaroe, et al., 2010; Fan et al., 2010; Kretschmer 
et al., 2011; Ma, Kosorok, Huang, & Dai, 2011; Schrauder et al., 2012). However, both of the above methods 
have disadvantages; for example, the wrapper methods are challenged by the high dimensionality of the data 
whereas the filters ignore the relation between the features. For example, mRNA that is extracted from 
peripheral blood cells has been used by a Norwegian group for analysing the expression of 1,368 genes 
extracted from peripheral blood cells of 56 women: 24 breast cancer and 32 healthy, for early detection of 
breast cancer. The study used wrapper method for feature selection and correctly predicted 82% of the 
samples using 37 probes (29 genes) (Sharma et al., 2005). To confirm the results of this study, a larger 
sample of 11,217 genes extracted from 130 women was analysed (Aaroe, et al., 2010). Aaroe, et al. (2010) 
used Partial Least Square Regression (PLSR) and Jackknife testing (Wu., 1986) with dual leave one out cross 
validation for feature selection and classification. The PLSR with leave one out cross validation was used to 
reduce the dimensionality of the data by selecting the optimum number of latent variables. This is a set of 
variables that are selected by analysing the covariance between the gene expression vectors and the class 
label. The regression also returns the regression coefficient for each gene. The Jackknife testing method is 
used to select the variables that have regression coefficient different from 0 with p-value <0.05. The study 
obtained a set of 738 probes that differentiated healthy from cancer samples with 79.5% prediction accuracy, 
80.6% sensitivity, and 78.3% specificity.  The study compared the 738 genes with the 29 genes obtained in 
the previous study (Sharma, et al., 2005) and found that 20 out of 29  genes were not significant in relation to 
the disease status in the present study (Aaroe, et al., 2010). The hypothesis that a larger sample could increase 
prediction accuracy was not shown in this case. It used filtering methods for feature selection that ignored the 
biological relation between genes and selected the genes based on the ability of individual genes in 
differentiating cancer form control cases. In addition, the method selected a large number of genes compared 
with the number of samples as inputs for the classifier which can negatively affect the outcomes. 
Furthermore, the accuracy of current CAD systems based on mRNA is about 79% and needs further 
enhancement in order to save the lives of the undetected. 
Gene co-expression provides key information to understand living systems, where the co-expressed genes are 
often involved in the same biological pathway (Yip & Horvath, 2007). Therefore, similarity between genes 
may reflect the biological relation between them, where the genes with high similarity may have similar 
biological function or may be a part of the same (Yip & Horvath, 2007; Zhang. & Horvath, 2005). There are 
several ways to compute the similarity between genes. The most common for gene expression data is Pearson 
Correlation Coefficient (PCC) and it is a measure that reflects the linear relationship between a pair of genes. 
The PCC takes values in the range from +1 to -1. A correlation of +1 means that there is a perfect positive 
linear relationship between variables and -1 means that there is a perfect negative linear relationship between 
variables. However, PCC considers each pair of variables in isolation to other variables. From a biological 
perspective, the relationships with other variables, genes or proteins, should be taken into account. This is 
because if a pair of genes shares relations with other genes, they all may be similar and may belong to the 
same pathway or may have similar biological functions (Yip & Horvath, 2007; Zhang. & Horvath, 2005).  
A meaningful approach to increase the diagnostic accuracy of mRNA CAD systems is to incorporate 
biological relations between genes that would require novel gene selection methods that consider biologically 
significant relations between genes. Then, incorporate the selected genes into a CAD system. In this paper, 
we aim to introduce a novel feature selection method called Bi-biological filter enhanced through Best First 
Search with Support Vector Machines (BFS-SVM).  
2. MATERIALS AND METHODS 
In this study we used 121 samples (67 malignant and 54 benign) that were collected by (Ullevål University 
Hospital and Haukeland University Hospital in Norway) between 2002-2004. The malignant group contains: 
10 samples with ductal carcinoma in situ and 57 invasive carcinoma samples spread across a number of 
severity Grades from I to III. Invasive carcinoma samples include 49 Ductal, 4 Lobular and 4 other invasive 
types. The dataset also contains 12 benign cases and 42 normal cases with neither benign nor malignant 
findings. Each sample contains 11, 217 genes (7351 known genes and 3866 unknown genes). The known 
genes are genes that have gene symbols and gene IDs where the unknown genes are those with no symbols 
and IDs at this stage. In this study, we only used the 7351 known genes. The samples are publicly available 
664
Al-yousef et al., Gene expression based Computer Aided diagnostic system for Breast Cancer: A novel biological filter 
for biomarker detection  
in the NCBI's Gene Expression Omnibus through GEO: GSE16443 accession number. The data is already 
pre-processed, where the effect of the background has been removed, normalised and summarised.  
Learning tasks, such as classification and clustering are challenged by high dimensional data. Such data may 
have a lot of noisy features which make learning task very complex. The process of removing noisy data 
(irrelevant and redundant) or choosing a subset of features (relevant) from a given set of features is called 
feature selection (Blum and Langley, 1997; Gilad-Bachrach et al., 2004). In this research we used a new 
method of feature selection called Bi-Biological Filter with further enhancements through Best First Search 
with SVM wrapper (BiBio-BFSS). This method contains two main steps: bi-biological filter and Best First 
Search with SVM wrapper. The bi-biological filter also contains two steps; neither cancer nor healthy 
biomarker elimination followed by healthy biomarker removal. The output genes from Bi-Biological filter 
are used as inputs to BFS-SVM wrapper to select a smaller set of genes for classification. 
2.1 Bi-biological filter 
This step is responsible for selecting a group of genes that are strongly related to breast cancer by using gene 
co-expression networks as described by Zhang and Horvath ( 2005). The first step is designed for removing 
the biomarkers or groups of genes that are not shared between the cancer cases (neither cancer nor healthy 
groups). This type of groups may result from noise in the dataset or other disease biomarkers shared between 
cancer cases in the study. The second step is to filter out the healthy biomarkers from the selected biomarkers 
found in the first step. 
2.1.1 Neither cancer nor healthy biomarker filtering 
This is to remove the genes that are not shared between all cancer cases. To do this, we randomly divided the 
malignant dataset into two sub-datasets, 33 samples assigned to M1 and 34 samples to M2. Then, the genes 
of each subset were divided into functional groups as follows: 
1- Build Co-expression Network described by Zhang and Horvath (2005) as follows: 
a. Find the correlation matrix (similarity matrix) using Pearson Correlation Coefficient (PCC) between 
gene i and gene j (Equation 1) for all pairs of genes in the set.   
PCCij=
௡	∑ ௫ೕೠ௫೔ೠ	೙ೠసభ ି∑ ௫೔ೠ	 ∑ ௫ೕೠ೙ೠసభ೙ೠసభ
ට௡	∑ ௫೔ೠమ೙ೠసభ ି(∑ ௫೔ೠ	)೙ೠసభ మට௡	∑ ௫ೕೠమ೙ೠసభ ି(∑ ௫ೕೠ )೙ೠసభ మ
 (1) 
 
where n is the number of samples, xju represents the expression value of gene j in sample u. 
To highlight strong relations, dampen weak correlations and to convert the network to scale-free topology we 
powered the absolute value of PCC to β where β is an integer number (Equation 2). 
wij =หܲܥܥ௜௝หఉ  (2) 
2- Obtain the Topology overlap between all pairs of genes: 
a. Find the degree or the connectivity value ci of gene i (Equation 3)  
ܿ௜ = ∑ ݓ௜௝௡௝ୀଵ
௜ஷ௝
       (3) 
where wij is the similarity value between gene i and j from step 1.           
b. For each pair of genes we find Iij, where Iij is a number between 0 and n as in Eq. 4 where wui is the 
similarity value; a high value of Iij means that there is a high number of shared genes between i and j 
and low value means that there is no or few shared genes between i and j. 
ܫ௜௝ = ∑ ݓ௨௝௡௨ୀଵ௨ஷ௝,௜ ݓ௨௜  
  (4) 
c. Now, we use the topological overlap similarity between each gene pair (Equation 6) 
ݐ௜௝ = ூ೔ೕା௪೔ೕ୫୧୬൫௖೔,௖ೕ൯ାଵି௪೔ೕ  (6) 
The matrix containing all tij is called Topological Overlap Matrix (TOM) and it is plotted in a weighted 
undirected graph where each gene is represented as a vertex and the edge between the pair of genes is 
weighted by the topological overlap similarity tij value. 
Module extraction 
Clustering plays an important role in data analysis. In biology, especially with high dimensional data, 
clustering has been used to reduce the dimensionality of data by grouping the similar dimensions. The 
module is a group of genes working together to do a specific biological function. From the above definition, 
the genes that are strongly correlated to each other may belong to one pathway or do similar functions. To 
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find the clusters of genes, this work uses Spectral Clustering. To apply spectral clustering on TOM graph we 
follow the following steps as described by Ng et al. ( 2001): 
1. Find the  degree of each vertex on the graph (Equation 7):  
݀௜ = ∑ ݐ௜௝௡௝ୀଵ   (7) 
2. Next find the graph’s Normalised Laplacian matrix (L) (Equation 8): 
݈௜௝ = ቐ
1												 ݅ = ݆
ݐ௜௝
ඥ݀௜ ௝݀	
			 ݅ ≠ ݆  (8) 
The normalised spectral clustering is known to outperform the non-normalised version in high dimensional 
data (Ng. et al., 2001). So we use normalised spectral clustering. 
Now we perform spectral clustering as follows:  
a- Find all eigenvalues and eigenvectors for the normalised Laplacian matrix. 
b- Next step is to determine the number of sub-graphs or clusters in the gene co-expression graph. This is 
done by selecting K representative eigenvectors from the n eigenvectors of the graph, where K is much 
smaller than n, in order to reduce the dimensionality of the data and to select the number of clusters.  
c- Let V є Rnxk be the matrix containing the selected eigenvectors v1, v2, v3, …, vk as columns. Form the 
matrix U by normalizing the row sums to 1 (Equation 9). Now, genes of the original adjacency matrix is 
represented by lower dimensional matrix U, where row i in U represents gene i in original matrix: 
u୧୨ = ୴౟ౠ
(∑ ୴౟మౣౡౣ సభ )
భ
మ
  (9) 
d- Gene clustering: for i=1, …, n , let yi є Rk be the vector corresponding to ith row of U. Cluster the points 
yi with k-means algorithm into clusters C1,…,Ck. 
Selection of shared clusters 
By the end of the above step, the genes in M1 and M2 
datasets have been divided into functional groups. In 
the current step, we select the shared groups of genes 
between M1 and M2 (Figure 1).  
A direct comparison between all genes in the groups 
is difficult; therefore, we select the hub genes for each 
cluster and the comparison takes place on hub gene 
level instead of all genes. To select the hub genes of a 
cluster, we find the within cluster connectivity for 
each gene (Equation 3) and select the m genes with 
the highest connectivity, a relatively small number, as hub genes. Selecting more than one hub gene allows 
partial similarity between a pair of clusters where clusters are considered shared if one or more hub genes are 
shared between two clusters.  
By the end of this step, neither cancer nor healthy clusters are removed and we keep only the shared groups 
that represent ‘cancer and healthy biomarkers’. 
2.1.2 Removal of healthy biomarkers 
This step is for filtering out the healthy biomarkers from the selected biomarkers in the shared gene set and to 
keep only the probable cancer biomarkers by applying the following steps: 
1. Build the co-expression gene network for the healthy dataset as described previously using the method of 
Zhang and Horvath (2005) and apply the spectral clustering to extract the healthy biomarkers as 
described above. 
2. Extract the hub genes for the ‘healthy’ clusters. 
3. Find the shared clusters between the ‘healthy’ clusters found here and the clusters containing ‘cancer and 
healthy biomarkers’ found previously.   
4. Delete the shared clusters found in step 3 from the ‘cancer and healthy biomarkers’ set. This provides a 
set of clusters that are potential cancer biomarkers.  
2.2  Best First Search and SVM with 5-fold cross validation wrapper 
In this step we use the forward BFS and the accuracy of SVM with K-fold cross validation to find the subset 
of genes that strongly relate to breast cancer from the output genes of the bi-biological filter. 
 
Figure 1. The shared clusters between M1 and M2 
cancer subsets. Red colour represents the clusters 
that were in M1 only, blue represents the clusters 
that were in M2 only and yellow represents the 
shared clusters between M1 and M2 
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2.3. Classification and evaluation 
This paper applies three supervised classifiers: Multilayer Feed Forward Neural Network (MFFNN) 
optimised/pruned by clustering correlated weighted hidden neuron outputs developed by Samarasinghe 
(2010), Support Vector Machine (SVM)  and Linear Discriminant Analysis (LDA). The results of each 
classifier are evaluated using False Positive rate (FP), False Negative rate (FN), Sensitivity, Specificity and 
Accuracy measures.    
3. RESULTS AND DISCUSSION 
3.1. Feature selection 
As mentioned earlier, this step is divided into two 
main steps; Bi-biological filter and Best First 
Search supported SVM with 5-fold cross 
validation wrapper method. 
3.1.1 Neither cancer nor healthy biomarker 
filter: 
The cancer dataset is divided randomly into two subsets; cancer1 (M1) and cancer2 (M2). The cancer1 subset 
contains 33 samples and cancer2 contains 34 samples; both subsets contain 7351 mRNA of genes. By 
applying spectral clustering on the TOM of cancer1 and TOM of cancer2 we found that cancer1 dataset was 
divided into 17 clusters and cancer2 into 16 clusters. Then for each cluster we selected two hub genes and 
found five clusters shared between cancer1 and cancer2 datasets (Table 1).  This removes all biomarkers 
which were not shared between cancer1 and cancer2 and only the shared ones are carried to the next step for 
filtering out healthy ones.   
3.1.2 Removal of healthy biomarkers: 
In this step, we analysed the healthy dataset to find all healthy biomarkers. The analysis revealed that the 
genes in the healthy dataset were spread over 15 different clusters. Then, for each healthy cluster we also 
extracted two representative hub genes. By comparing the healthy hub genes and the hub genes that were 
shared between cancer1 and cancer2 datasets (Table 1), we found that 2 out of 5 clusters (2 and 5) in Table 1 
were found in the healthy dataset and considered to be healthy biomarkers. Thus, the remaining three clusters 
(1, 3 and 4) in Table 1 are considered to be the breast cancer biomarkers. Because we allowed partial 
similarity, the shared genes between pairs of clusters (cancer1-cancer2) were selected and considered to be 
breast cancer biomarkers. The total number of selected genes was 415. 
Now, for genes in each cluster, we investigated the biological processes related to the genes of that cluster 
using The Database for Annotation, Visualization and Integrated Discovery (DAVID) (Dennis et al., 2003) 
and selected the processes that had False Discovery Rate (FDR) less than 20% and (p-value<0.05). 
For the first cluster (1) we found that apoptosis (GO:0006915) and regulation of apoptosis (GO:0042981) 
were the most important processes that differentiated normal and cancer cells. Several previous studies found 
apoptosis in relation to breast cancer where the apoptosis process in cancer patients was weaker compared to  
healthy ones (Feng et al., 1995; Graham & Clarke, 1997; Haldar, Negrini, Monne, Sabbioni, & Croce, 1994; 
Parton, Dowsett, & Smith, 2001). We found that the second cluster (3) relates to the cellular respiration 
process (GO:0045333), which is the enzymatic release of energy from organic compounds that either 
requires oxygen (aerobic respiration) or does not (anaerobic respiration) (European Molecular Biology 
Laboratory, 2011) (European Molecular Biology Laboratory, 2011), and several studies have found its  
relation to breast cancer (Simonnet et al., 2002; Warburg, 1956). Another process related to the genes of 
cluster (3) was epithelial cell differentiation process (GO:0030855) where a relatively unspecialised cell 
acquires specialised features of an epithelial cell (European Molecular Biology Laboratory, 2011), and it was 
found in relation to breast cancer in Beitsch and Clifford (2000) study.  In the last cluster (4), we found  
processes in relation to producing energy necessary for cellular processes. Glucose is an important source of 
energy in the body and it is considered as fuel for a cell. Without energy, cells cannot perform their natural 
processes. Cancer cells are characterised by uncontrolled and rapid division so there is a need for providing 
cancer cells with a larger amount of glucose and speed up the process of producing energy from it (Annibaldi 
& Widmann, 2010). 
By the end of this investigation we found that genes in the same cluster work together to carry out the same 
biological processes which provides support for the biological relation between the genes. Furthermore, we 
Table 1. The shared clusters between cancer1 and cancer2 













1 11 1 22827 SIAHBP
2 13 2 6139 RPL17
3 6 4 8786 RGS11
4 8 6 150372 NFAM1
5 15 15 79143 LENG4
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Table 2. The performance of different classifiers using the 13 
selected genes   (SN- sensitivity, SP- specificity and Ac-
accuracy). 
Classifier SN  SP  FN rate FP rate Ac  
SVM 86.6% 81.5% 16.98% 14.7% 84.3% 
LDA 82.1% 79.6% 21.8% 16.7% 80.9% 
MFFNN 94.02% 92.6% 7.4% 5.97% 93.4%
found that the relationship between the biological processes of the groups and breast cancer are strong which 
also provides support for the selected group of biomarkers. 
3.1.3 Best First Search and SVM with 5-fold cross validation wrapper  
The Bi-Biological filter selected 415 genes that were spread over 3 clusters; these clusters are potential breast 
cancer biomarkers. But we still needed to reduce the dimensionality of the data and select a subset of genes 
from the 415 genes for classification. To do this, we applied the BFS and SVM with 5-fold cross validation 
wrapper for gene selection as described previously. After 16 iterations, the algorithm was stopped 
because there were no improvements in 
iterations 14, 15 and 16 (number of fails 
m=3). The highest accuracy that was 
obtained by the wrapper was at iteration 
number 13 with 85.1% classification 
accuracy; 88.05% sensitivity and 81.4% 
specificity (Figure 2) using 13 genes 
(DAPK3, CTDSP1, CXX1, RCOR3, 
MYL4, YWH, ABGMEB2, GPR78, ILK, 
HSPC171, ACAT2, PRKRIP1, PP3856).  
Also, we found DAPK3 (Death-
Associated Protein Kinase 3) obtained the 
highest individual classification accuracy 
(iteration1).  
3.2 Classifications 
The thirteen selected genes were used as 
input for the three classifiers, Multilayer 
Feed Forward Neural Network (MFFNN) 
optimised with hidden network pruning 
by a novel method with 5-fold cross 
validation, SVM with Leave One Out 
Cross Validation (LOOCV) and Linear 
Discriminant Analysis (LDA) with 
LOOCV. Then the output results of each 
classifier were evaluated using the 
sensitivity, specificity, FP, FN and accuracy measures (Table 2). From the outputs of different classifiers we 
found the MFFNN was the superior classifier with 94.02% sensitivity, 92.6% specificity and 93.4% 
accuracy. 
Now, reviewing the false positive rate and FN cases of the best classifier, MFFNN, we found 2 out of 4 FP 
cases had a cyst or benign tumour which means that the presence of benign findings in the breast may reduce 
the specificity of our system. The grades of FN cases were: one case of grade one, two cases of grade two 
and one case not classified. From these FN cases we found that our system correctly classified 92.8% of 
grade one cases and 90.9% of grade two cases and the local sensitivity values of both grades are close to the 
overall sensitivity of the system. This means that our system successfully predicts breast cancer in early 
stages.  
From the literature review we found that there was only one blood based mRNA CAD for early detection of 
breast cancer (Aaroe, et al., 2010). This CAD system extracted 738 mRNA probes as breast cancer 
biomarkers using a filtering method. These biomarkers were used to classify the samples into healthy and 
cancer cases. The accuracy, sensitivity and specificity value for Aaroe et al. (2010) CAD system were 79.5%, 
80.6%, 78.3%, respectively. By comparing our CAD system results with their system we found that the 
accuracies of all classifiers in our CAD systems are better. Specifically, the diagnostic accuracy of LDA 
classifier was enhanced by 2% and the SVM improved the diagnostic accuracy by 5.5%. The significant 
improvement of our BC-CAD over Aaroe et al. (2010)  system was in the accuracy, sensitivity and 
specificity values of MFFNN where our system obtained 93.4%, 94.02% and 92.6%, respectively, which 
means that about 14% of cancer cases misdiagnosed in Aaroe et al.  (2010) system are diagnosed correctly by 
our system and hence more lives could be saved. Furthermore, using 738 probes for classification reduces the 
performance of classifiers due to high dimensionality of data compared with 13 genes in our study, 56 times 
less than in their study. 
Figure 2. The output accuracy from the Best First Search and SVM 
with 5-fold cross validation wrapper for 16 iterations. The X-axis 
represents the iteration number and the Y-axis represents the 
corresponding accuracy value. 
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4. CONCLUSION  
In this study we introduced a new method for breast cancer biomarker selection and we called this Bi-
Biological filter and Best first Search (BFS) supported SVM with K-fold cross validation and we 
successfully identified 13 genes as breast cancer biomarker in the blood. Also, we evaluated the diagnostic 
accuracy of three classifiers MLFFNN, LDA and SVM. The best results were obtained using MFFNN with 
93.4% classification. Furthermore, about 14% of cancer cases misdiagnosed in the previous CAD system 
(Aaroe, et al., 2010) were diagnosed correctly in our system and hence more lives could be saved. In future, a 
larger dataset will be used for validation of the performance of our method.  
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